Overcoming scientific barriers in the transition from in vivo to non-animal batch testing of human and veterinary vaccines-Reference-Cited by-同舟云学术

Overcoming scientific barriers in the transition from in vivo to non-animal batch testing of human and veterinary vaccines

Published:2021-09-22 Issue:10 Volume:20 Page:1221-1233
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

van den Biggelaar Robin H. G. A.¹^ORCID,Hoefnagel Marcel H.N.²^ORCID,Vandebriel Rob J.³^ORCID,Sloots Arjen⁴,Hendriksen Coenraad F.M.⁴,van Eden Willem¹^ORCID,Rutten Victor P. M. G.¹⁵^ORCID,Jansen Christine A.¹⁶^ORCID

Affiliation:

1. Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands

2. Quality Department, Medicines Evaluation Board, Utrecht, The Netherlands

3. Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands

4. Intravacc (Institute for Translational Vaccinology), Bilthoven, The Netherlands

5. Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Pretoria, South Africa

6. Cell Biology and Immunology Group, Department of Animal Sciences, Wageningen University and Research, Wageningen, The Netherlands

Funder

the Dutch Ministry of Agriculture, Nature and Food Quality, and the National Institute of Public Health & the Environment

the Dutch Ministry of Agriculture, Nature and Food Quality, and Intravacc

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1977628

Reference129 articles.

1. From empiricism to rational design: a personal perspective of the evolution of vaccine development

2. Vaccine quality—can a single standard be defined?

3. Commission to the European Parliament and the Council. 2019 Report on the Statistics on the Use of Animals for Scientific Purposes in the Member States of the European Union in 2015-2017. 2020.

4. Milne C, Buchheit KH. EDQM’s 3R activities in the field of quality control of vaccines. ALTEX. 2012;1/12.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intestinal in vitro transport assay combined with physiologically based kinetic modeling as a tool to predict bile acid levels in vivo;ALTEX;2024

2. Development of subunit vaccine: A step forward toward cost-effective technology of vaccine candidate discovery;Reverse Vaccinology;2024

3. Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of National Control Laboratories and National Regulatory Authorities;Biologicals;2023-11

4. Rational arguments for regulatory acceptance of consistency testing: benefits of non-animal testing over in vivo release testing of vaccines;Expert Review of Vaccines;2023-04-19

5. Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assays;Expert Review of Vaccines;2023-03-06